Oncogene - Table of Contents alert Volume 33 Issue 40

If you are unable to see the message below, click here to view.

Advertisement Validated ChIP antibodies you can TRUST - and try a sample!   Partnering with epigenetics experts in the BLUEPRINT epigenome consortium, Diagenode has developed completely validated epigenetics antibodies with the highest specificity and sensitivity available. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with validated antibodies you can trust. Learn more and try a sample today. TABLE OF CONTENTS Volume 33, Issue 40 (October 2014) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Communications soon to be fully open access   From 20th October Nature Communications, will become fully open access for all new submissions. If an author has a manuscript they wish to submit to the journal via the subscription route, they must submit before 20th October. After this date all new submissions, if accepted, will be published open access and an article processing charge (APC) will apply. For any questions on the switch, open access or advice on policies and funding, visit our website, read the press release or contact our dedicated support team at openaccess@nature.com. Review Top Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression G Cagnoni and L Tamagnone Oncogene 2014 33: 4795-4802; advance online publication, November 11, 2013; 10.1038/onc.2013.474 Abstract | Full Text Original Articles Top Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair J-Y Park, T R Singh, N Nassar, F Zhang, M Freund, H Hanenberg, A R Meetei and P R Andreassen Oncogene 2014 33: 4803-4812; advance online publication, October 21, 2013; 10.1038/onc.2013.421 Abstract | Full Text MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes F Liu, J Gong, W Huang, Z Wang, M Wang, J Yang, C Wu, Z Wu and B Han Oncogene 2014 33: 4813-4822; advance online publication, October 28, 2013; 10.1038/onc.2013.428 Abstract | Full Text RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789 B Nadratowska-Wesolowska, E M Haugsten, M Zakrzewska, P Jakimowicz, Y Zhen, D Pajdzik, J Wesche and A Wiedlocha Oncogene 2014 33: 4823-4836; advance online publication, October 21, 2013; 10.1038/onc.2013.425 Abstract | Full Text Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness M Tamura, Y Sasaki, R Koyama, K Takeda, M Idogawa and T Tokino Oncogene 2014 33: 4837-4846; advance online publication, November 4, 2013; 10.1038/onc.2013.427 Abstract | Full Text microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1 M Fujiya, H Konishi, M K Mohamed Kamel, N Ueno, Y Inaba, K Moriichi, H Tanabe, K Ikuta, T Ohtake and Y Kohgo Oncogene 2014 33: 4847-4856; advance online publication, October 28, 2013; 10.1038/onc.2013.429 Abstract | Full Text Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression L H Chan, W Wang, W Yeung, Y Deng, P Yuan and K K Mak Oncogene 2014 33: 4857-4866; advance online publication, October 21, 2013; 10.1038/onc.2013.433 Abstract | Full Text HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer C-H Lai, K-S Park, D-H Lee, A T Alberobello, M Raffeld, M Pierobon, E Pin, E F Petricoin III, Y Wang and G Giaccone Oncogene 2014 33: 4867-4876; advance online publication, October 28, 2013; 10.1038/onc.2013.439 Abstract | Full Text Short Communication Top The kinetics of ER fusion protein activation in vivo OPEN C H Wilson, I Gamper, A Perfetto, J Auw, T D Littlewood and G I Evan Oncogene 2014 33: 4877-4880; advance online publication, March 24, 2014; 10.1038/onc.2014.78 Abstract | Full Text Advertisement Now open for submissions, Scientific Data is an open access, peer-reviewed publication for descriptions of scientifically valuable datasets. Our primary article-type, the Data Descriptor, is designed to make your data more discoverable, interpretable and reusable, plus we offer data curation advice as part of our service to authors. Submit your data descriptor now!   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.